VYEPTI 3V

Trademark usage description

pharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and dis Read More

Classification Information

Class [005]
Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases namely pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, pharmaceutical preparations for the treatment of immunologic diseases namely autoimmune diseases, immunologic deficiency syndromes, anti-inflammatories, pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, and neurological disorders and conditions namely pharmaceutical preparations for the treatment of neurological diseases namely, Alzheimer's, Huntington's disease, cerebral palsy, pharmaceutical preparations for the treatment of neurological disorders namely brain injury, spinal cord injury, seizure disorders.

Classification kind code

Class [010]
Surgical and medical apparatus and instruments, namely, knives for surgical use, lasers for surgical and medical use, medical and surgical catheters, medical and surgical laparoscopes, surgical clamps, surgical drills, surgical instruments, dispensers, namely, aerosol dispensers for medical purposes, needles, syringes; medical devices, namely, syringes and pumps for administering drugs, syringes and needles for injections and for medical purposes; apparatus and instruments, namely, test kits comprised of medical instruments for general examination for testing neurological diseases, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, central nervous system movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency for diagnostic purposes; integrated medical systems containing medical apparatus, namely drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes, needles, syringes, and software for information storage, information management, and for accessing information in the fields of neurology, neurological diseases and disorders, and brain diseases and disorders for use in Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments, namely, drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes for information, guidance, management and control of medicines.

Classification kind code

Mark Details

Serial Number

2182887

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 26^th Mar 2025	Advertised
Submitted for opposition 26 on 27^th Feb 2025	Approved
Submitted for opposition 27 on 27^th Feb 2025	Approval Notice Sent
Submitted for opposition 22 on 26^th Mar 2024	Search Recorded
Submitted for opposition 20 on 26^th Mar 2024	Examiner's First Report
Submitted for opposition 67 on 7^th Oct 2022	Agent Name Changed
Submitted for opposition 287 on 19^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 2^th May 2022	Filed
Submitted for opposition 1 on 2^th May 2022	Created
Submitted for opposition 31 on 2^th May 2022	Formalized